semaglutide with cagrilintide Updates in Medicine | 🔬 REDEFINE 2: CagriSema in T2D + Obesity Original article link in bio 👥 Phase 3a RCT in 1206 adults T2D (BMI ≥27, HbA1c 7–10%) 💉 cagrilintide and semaglutide blend Cagrilintide/Semaglutide

Semaglutide (the active ingredient in Ozempic and Wegovy) and Tirzepatide (the active ingredient in Mounjaro) are two powerful FDA-approved medications within this class that have demonstrated remarkable effectiveness in promoting significant, sustainable weight loss

The animal experiments were approved by the Animal Ethics Committee of Tianjin Medical University and Welfare Committee

Minimally Invasive Options For Select Cases For smaller areas of concern, we also offer MyEllevate for the neck, chin liposuction, and labiaplasty all performed under local anesthesia in my Raleigh office

On 21 May 2026 , Lilly published the long-awaited topline results from the TRIUMPH-1 Phase 3 trial, and the data is striking: participants on the highest dose lost an average of 28.3% of their body weight at 80 weeks , with 45.3% of patients losing 30% or more a threshold previously only achievable with bariatric surgery

Emily Kirby, right here in Fort Worth